Amyloid burden

There are 105 papers on amyloid burden in aging research: 2 trials and 75 observational studies in people, 16 in animals, 11 reviews. The newest story, Nov 11, 2026: “Air pollution changed brain immune cell activity in mice”.

Biomarker

105 papers study it372 more mention it61 findings

22 new papers in 30 daysSee all 477 papers on amyloid burden

At a glance

Higher amyloid burden is linked with worse cognition and memory in human cohorts, including people cognitively normal at baseline. A study finds no clear link with cognitive impairment without dementia. Mouse studies report reductions with galectin-1 in aged Alzheimer’s models and with rapamycin begun after disease onset in symptomatic hAPP mice.

61 findings in 57 papers from 2012 to 2026, 8 of them since June 2026

“GM aging aligned more closely with amyloid burden”
Tissue- and compartment-resolved brain age reveals vascular-metabolic and neurodegenerative agingResearch square2026doi:10.21203/rs.3.rs-10808325/v1
  • Human trial2
  • Humans75
  • Animals14
  • Model organisms2

Interventions

11

Fine particulate matter air pollution

upin mice1

1 study
  1. Fine particulate matter air pollution increases amyloid burden in mice (5xFAD mice compared with filtered air).

    “In 5xFAD mice it additionally increased amyloid burden.”

    Animals5xFAD mice compared with filtered airconcentrated ambient PM2.5brain20 weeks

    Air pollution changed brain immune cell activity in mice

    Journal of neuroinflammation

More on Fine particulate matter air pollution

P4B

downin mice1

1 study
  1. P4B decreases amyloid burden in mice (aged APP/PSEN1 transgenic mice).

    “In vivo administration of P4B to aged APP/PSEN1 mice significantly reduced the amyloid burden, neuroinflammatory markers, and microglial activation in hippocampal and cortical regions.”

    Animalsaged APP/PSEN1 transgenic micehippocampus and cortex

    Papaverine-Derived Dual-Active Modulator Ameliorates Alzheimer's Disease Pathology in Aged APP/PSEN1 Transgenic Mice

    Journal of medicinal chemistry

More on P4B

Galectin-1

downin mice1

1 study
  1. Galectin-1 decreases amyloid burden in aged AD mice (PDAPPJ20).

    “The administration of supraphysiological levels of Gal‐1 to aged AD mice resulted in a notable reduction in amyloid burden”

    Animalsin aged AD mice (PDAPPJ20)

    Galectin‐1 as a therapeutic strategy and a biomarker for Alzheimer's disease

    AAIC 2025 abstract

More on Galectin-1

Physical activity

no changein humans1

1 study
  1. Physical activity was not clearly linked with amyloid burden in humans (elevated baseline amyloid).

    “this beneficial association was not related to lower amyloid burden at baseline or longitudinally.”

    Humanselevated baseline amyloid

    Physical activity as a modifiable risk factor in preclinical Alzheimer's disease

    Nature medicine

More on Physical activity

Dietary sodium

no changein humans1

1 study
  1. Dietary sodium was not clearly linked with amyloid burden in humans among the deceased, compared to the middle quintile.

    “but not with amyloid burden or infarcts”

    Humansamong the deceased, compared to the middle quintilebrainlowest quintilen = 717

    Association of dietary sodium intake with late-life cognitive decline and postmortem neuropathology in community-dwelling older adults

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Dietary sodium

Positive childhood experiences

no changein humans1

1 study
  1. Positive childhood experiences were not clearly linked with amyloid burden in humans.

    “PCEs were not associated with hippocampal volume or amyloid burden in the combined sample or across individual ethnocultural groups.”

    Humansbrainn = 281

    Positive Childhood Experiences, Cognition, and Biomarkers of Alzheimer's Disease

    International journal of environmental research and public health

More on Positive childhood experiences

Metoprolol + simvastatin + aspirin + paracetamol + citalopram

downin mice1

1 study
  1. Metoprolol + simvastatin + aspirin + paracetamol + citalopram decreases amyloid burden in mice.

    “reduced amyloid burden and neuroinflammation, and modulated AD-associated metabolomic signatures in male mice”

    Animalsmales

    Commonly prescribed multi-medication therapies exert sex-specific effects on Alzheimer's disease pathology and metabolomic profiles in AppNL-G-F mice: Implications for personalized therapeutics in aging

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Metoprolol + simvastatin + aspirin + paracetamol + citalopram

Microelectrode implantation

upin mice1

1 study
  1. Microelectrode implantation increases amyloid burden in mice.

    “simultaneously elevating amyloid burden at the electrode-tissue interface”

    Animalsbrain tissue at the electrode-tissue interface

    Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer's disease

    Journal of neural engineering

More on Microelectrode implantation

Caloric restriction mimetics

downin reviews1

1 study
  1. Caloric restriction mimetics decrease amyloid burden (via autophagy).

    “the beneficial effects of CR- or caloric restriction mimetics-induced autophagy in alleviating amyloid burden and tau pathology of AD were also discussed”

    Reviewvia autophagy

    The effects of caloric restriction and its mimetics in Alzheimer's disease through autophagy pathways

    Food & function

More on Caloric restriction mimetics

Rapamycin

downin mice1

1 study
  1. Rapamycin decreases amyloid burden in mice (treatment started after disease onset in symptomatic hAPP mice).

    “decreased amyloid burden”

    Animalstreatment started after disease onset in symptomatic hAPP micebrain

    Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

More on Rapamycin

All 11

Effects

5

Cognitive function

downin humans3

3 studies
  1. Amyloid burden is linked with worse cognitive function in humans (cognitively unimpaired older adults) (p's < .05, r = .28-.51).

    “Participants in the elevated amyloid group performed worse on the RIMCAT and perceptual discrimination, familiarity memory, and feature binding tasks”

    Humanscognitively unimpaired older adultsn = 24

    Associations between Digital Cognitive Assessment and Amyloid Burden in Cognitively Unimpaired Older Adults

    AAIC 2025 abstract

  2. Amyloid burden is linked with worse cognitive function in humans.

    “A higher amyloid burden and smaller HV were associated with faster cognitive decline.”

    Humansn = 192

    Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study

    Neurology

  3. Amyloid burden is linked with worse cognitive function in humans (cognitively normal at baseline).

    “Higher baseline SUVR projected greater cognitive decline over 4 years.”

    Humanscognitively normal at baseline4 yearsn = 174

    Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship

    JAMA neurology

Depression

no changein humans1

1 study
  1. Amyloid burden was not clearly linked with depression in humans (cognitively unimpaired) (p = 0.68).

    “Regression analyses showed amyloid burden associated with anxiety (β = 0.04, standardized, p = 0.003) but not depression (p = 0.68).”

    Humanscognitively unimpairedbrainn = 4,492

    Preclinical amyloid pathology is associated with anxiety but not depression in cognitively normal older adults: Evidence for differential neuropsychiatric pathways

    The journal of prevention of Alzheimer's disease

Verbal memory function

downin humans1

1 study
  1. Amyloid burden is linked with worse verbal memory function in subjective cognitive decline.

    “A+SCD subjects showed greater decline in the verbal memory function compared with the A-SCD subjects after adjustment for age.”

    Humansin subjective cognitive decline24 months

    The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study

    Dementia and geriatric cognitive disorders

Cerebral oxygen extraction fraction

no changein humans1

1 study
  1. Amyloid burden was not clearly linked with cerebral oxygen extraction fraction in humans (APOE4 carriers and noncarriers).

    “Amyloid burden and OEF were independently associated with APOE4 but were not associated with one another, suggesting that the effect of APOE4 on OEF is not mediated by amyloid.”

    HumansAPOE4 carriers and noncarriersbrain

    Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden

    Radiology

More on Cerebral oxygen extraction fraction

Episodic memory

downin humans1

1 study
  1. Amyloid burden is linked with worse episodic memory in humans (amyloid-positive participants).

    “increasing baseline SUVR predicted an increasing decline in episodic memory”

    Humansamyloid-positive participants4 years

    Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship

    JAMA neurology

Upstream

8

WWOX

downin flies1

1 study
  1. WWOX decreases amyloid burden in flies (Wwox overexpression in an Aβ42 model).

    “overexpression of Wwox in neurons markedly reduced amyloid burden”

    Model organismsWwox overexpression in an Aβ42 modelneuron

    Raising gene activity reduces brain protein deposits in flies

    Brain communications

More on WWOX

APOE

upin humans1

1 study
  1. APOE is linked with higher amyloid burden in humans (compared with ε33) (β = 44.820).

    “Compared with ε33, ε24 (β = 18.340), ε34 (β = 23.850), and ε44 (β = 44.820) showed higher amyloid burden”

    Humanscompared with ε33

    APOE and amyloid-tau pathology in cognitively unimpaired older adults

    Alzheimer's & dementia (Amsterdam, Netherlands)

More on APOE

Female sex

upin humans1

1 study
  1. Female sex is linked with higher amyloid burden in humans (community-based adults without cognitive impairment) (B = 0.05; 95% CI, 0.02-0.07; P < .001).

    “Compared with men, women had greater amyloid burden”

    Humanscommunity-based adults without cognitive impairmentbrainn = 503

    Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort

    JAMA network open

Sleep latency

no changein humans1

1 study
  1. Sleep latency was not clearly linked with amyloid burden in humans (essential tremor) (β = 0.257, p = 0.324).

    “amyloid: β = 0.257, p = 0.324).”

    Humansessential tremorbrainn = 24

    Assessing Change in Sleep Latency as a Potential Indicator of Alzheimer’s Pathologies in Essential Tremor

    GSA 2025 abstract

More on Sleep latency

Subjective cognitive decline

upin humans1OR 1.71

1 study
  1. Subjective cognitive decline is linked with higher amyloid burden in humans (OR=1.71, 95% CI 1.05 to 2.80).

    “Greater ECog was also associated with higher amyloid‐SUVR (β=0.05,95%CI 0.01,0.09) and higher odds of amyloid‐positivity (OR=1.71,95%CI 1.05,2.80)”

    Humansbrain

    Associations of subjective cognitive decline with MRI biomarkers of neurodegeneration and vascular injury and amyloid PET in an ethnoracially diverse cohort

    AAIC 2025 abstract

Cognitive impairment no dementia

no changein humans1

1 study
  1. Cognitive impairment no dementia was not clearly linked with amyloid burden in humans (cognitively impaired, no dementia vs. cognitively normal).

    “there was no statistically significant difference between the groups in amyloid burden in this region”

    Humanscognitively impaired, no dementia vs. cognitively normalposterior cingulate and precuneusn = 113

    Cerebral perfusion and amyloidosis in the oldest-old

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Cognitive impairment no dementia

NREM sleep delta power

no changein humans1

1 study
  1. NREM sleep delta power was not clearly linked with amyloid burden in humans (cognitively unimpaired).

    “Delta power was neither associated with amyloid burden at baseline nor its accumulation over time, whatever the frequency band considered.”

    Humanscognitively unimpaired~21 monthsn = 127

    Multimodal neuroimaging correlates of spectral power in NREM sleep delta sub-bands in cognitively unimpaired older adults

    Sleep

More on NREM sleep delta power

RTN4R

upin mice1

1 study
  1. RTN4R increases amyloid burden in APP/PS1 mice.

    “NgR knockdown APP/PS1 mice showed simultaneous reduced amyloid burden and improved spatial learning and memory”

    Animalsin APP/PS1 mice

    Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression

    Aging cell

More on RTN4R

Associations

32

APOE

upin humans2

2 studies
  1. APOE is associated with amyloid burden in humans (dose-dependent by ε4 allele count; highest in ε4 homozygotes) (strong dose-dependent association).

    “APOE ε4 showed a strong dose-dependent association with amyloid burden and amyloid positivity”

    Humansdose-dependent by ε4 allele count; highest in ε4 homozygotesbrainn = 4,380

    APOE and amyloid-tau pathology in cognitively unimpaired older adults

    medRxiv : the preprint server for health sciencesPreprint

  2. APOE is associated with amyloid burden in humans.

    “APOE4 allele had robust correlations with increased amyloid burden in the fronto-temporo-parietal cortical areas after adjustment for age and sex”

    Humansn = 185

    Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals

    Research SquarePreprint

More on APOE

Calprotectin

upin humans2

2 studies
  1. Calprotectin is associated with amyloid burden in humans among individuals with AD dementia.

    “higher calprotectin was associated with greater amyloid burden as measured with PiB PET.”

    Humansamong individuals with AD dementia

    Gut inflammation associated with age and Alzheimer's disease pathology: a human cohort study

    Scientific reports

  2. Calprotectin is associated with amyloid burden in humans (amyloid-confirmed Alzheimer's disease dementia).

    “higher calprotectin was associated with greater amyloid burden among participants with an amyloid-confirmed AD dementia diagnosis.”

    Humansamyloid-confirmed Alzheimer's disease dementia

    Gut inflammation associated with age and Alzheimer’s disease pathology

    medRxivPreprint

More on Calprotectin

Neighborhood deprivation

mixedin humans1

1 study
  1. Neighborhood deprivation is associated with amyloid burden in humans (APOE ε4 carriers).

    “Amyloid burden was higher among low‐ADI APOE ε4 carriers.”

    HumansAPOE ε4 carriersbrainlow ADI

    Association of neighborhood deprivation with Alzheimer's disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE ε4 status

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Neighborhood deprivation

Gray matter brain age

upin humans1

1 study
  1. Gray matter brain age is associated with amyloid burden in humans across the Alzheimer's disease continuum.

    “GM aging aligned more closely with amyloid burden”

    Humansacross the Alzheimer's disease continuum

    Compartment-resolved brain aging reveals distinct vascular and neurodegenerative pathways

    Research squarePreprint

More on Gray matter brain age

EAmAge

upin humans1

1 study
  1. EAmAge is associated with amyloid burden in humans.

    “EAmAge was also associated with Alzheimer s disease-related biomarkers, including amyloid burden, reduced glucose metabolism and hippocampal atrophy.”

    Humans

    A lipidomic based metabolic age score for monitoring the effects of lifestyle and diet on metabolic disease risk

    Research squarePreprint

More on EAmAge

IL-6

upin humans1

1 study
  1. Amyloid burden is associated with IL-6 in humans (adjusted for sex, trisomy type, and collection site) (β = 0.005, p = 0.037).

    “Amyloid burden was positively associated with IL-6 (β = 0.005, p = 0.037).”

    Humansadjusted for sex, trisomy type, and collection site

    Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome

    Obesity (Silver Spring, Md.)

More on IL-6

Sleep

upin humans1

1 study
  1. Sleep is associated with amyloid burden in humans (cognitively unimpaired persons) (0.074 [0.008; 0.140], 0.028).

    “Greater variability in sleep fragmentation was also associated with amyloid burden (0.074 [0.008; 0.140], 0.028)”

    Humanscognitively unimpaired personsn = 223

    Longitudinal association between sleep and Alzheimer's pathology

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Sleep

Memory complaints

upin humans1

1 study
  1. Amyloid burden is associated with memory complaints in humans (cognitively unimpaired) (p = 0.008).

    “amyloid-positive participants reported higher memory complaints (p = 0.008) and AD concerns (p < 0.001) before status disclosure.”

    Humanscognitively unimpairedn = 4,492

    Preclinical amyloid pathology is associated with anxiety but not depression in cognitively normal older adults: Evidence for differential neuropsychiatric pathways

    The journal of prevention of Alzheimer's disease

Anxiety

upin humans1

1 study
  1. Amyloid burden is associated with anxiety in humans (cognitively unimpaired) (β = 0.04, standardized, p = 0.003).

    “Regression analyses showed amyloid burden associated with anxiety (β = 0.04, standardized, p = 0.003)”

    Humanscognitively unimpairedbrainn = 4,492

    Preclinical amyloid pathology is associated with anxiety but not depression in cognitively normal older adults: Evidence for differential neuropsychiatric pathways

    The journal of prevention of Alzheimer's disease

Sleep latency

upin humans1

1 study
  1. Sleep latency is associated with amyloid burden in humans (essential tremor) (r = 0.448, p = 0.028).

    “amyloid burden (r = 0.448, p = 0.028)”

    Humansessential tremorbrainn = 24

    Assessing Change in Sleep Latency as a Potential Indicator of Alzheimer’s Pathologies in Essential Tremor

    GSA 2025 abstract

More on Sleep latency

All 32

Funding

3 grants since 2018

National Institute on Aging$7.8MNational Institute of Mental Health$153K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human preprint associates amyloid burden with gray matter brain age across the Alzheimer's disease continuum; a separate human study reports that APOE increases amyloid burden compared with ε33.

  2. Summary written from the findings.

Latest

Dec 2025: 67Jan 2026: 21Feb 2026: 7Mar 2026: 8Apr 2026: 17May 2026: 7Jun 2026: 10Jul 2026: 9Aug 2026: 8Sep 2026: 15Oct 2026: 19Nov 2026: 9197 papers in 12 months
Journal of Neuroinflammation

Air pollution changed brain immune cell activity in mice

A 20-week mouse experiment found that genetic background shaped how brain immune cells responded to fine-particle air pollution.A 20-week mouse experiment found that genetic background shaped how brain immune cells responded to fine-particle air pollution.

Mouse studyMechanisms
Brain Communications

Raising gene activity reduces brain protein deposits in flies

Female flies producing human amyloid protein had a median lifespan of 47.5 days with increased Wwox gene activity, versus 29 days in controls.Female flies producing human amyloid protein had a median lifespan of 47.5 days with increased Wwox gene activity, versus 29 days in controls.

Fly studyMechanisms
Alzheimer's Research & Therapy

Spinal-fluid protein linked to Alzheimer’s progression

Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.

Cohort · 706 peopleMechanisms

See all 477 papers on amyloid burden